Skip to content
★ Sign in to follow
DM
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€2.3M

Latest filing published 15 Feb 2007 for ResMed Inc, €207k.

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

No signal scores available.

Donagh Mccarthy: trading record in brief

Donagh Mccarthy discloses dealings in ResMed Inc to SEC (Form 4). Between 9 February 2006 and 14 February 2007, the trades on record add up to 4 filings.

No open-market purchase appears, only 2 sales worth €2.3M. Besides market trades, the filings include 2 option exercises. So far in 2007, the count stands at no purchases and 1 sale.

Most recently, on 15 February 2007, the filings show an option exercise worth €207k in ResMed Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Donagh Mccarthy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◇
    DirectorExecutivesResMed Inc
    272,000 USD0SEC
    32,000 shares@ US$8.50ResMed Common StockSEC:0001140361-07-003704:0
  • ▼
    DirectorExecutivesResMed Inc
    2M USD0SEC
    32,000 shares@ US$49.60ResMed Common StockSEC:0001140361-07-003704:1
  • ◇
    DirectorExecutivesResMed Inc
    184,960 USD0SEC
    32,000 shares@ US$5.78ResMed Common StockSEC:0001140361-06-002078:0
  • ▼
    DirectorExecutivesResMed Inc
    1M USD0SEC
    32,000 shares@ US$41.28ResMed Common StockSEC:0001140361-06-002078:1

4 of 4 declarations